Personensuche
X
?
1
Differences in prescribed medicinal cannabis use by cannabi..:
Trevitt, Benjamin T. ; Bailey, Sasha ; Mills, Llewellyn...
PLOS ONE. 19 (2024) 2 - p. e0297092 , 2024
PLOS ONE. 19 (2024) 2 - p. e0297092 , 2024
?
2
The impact of changes in opioid dependency treatment upon C..:
Trevitt, Benjamin T. ; Hayes, Victoria ; Deacon, Rachel...
BMC Public Health. 24 (2024) 1 - p. , 2024
BMC Public Health. 24 (2024) 1 - p. , 2024
?
3
Community Outbreak of Pseudomonas aeruginosa Infections Ass..:
Trevitt, Benjamin T. ; Katelaris, Anthea L. ; Bateman-Steel, Catherine...
Emerging Infectious Diseases. 29 (2023) 10 - p. , 2023
Emerging Infectious Diseases. 29 (2023) 10 - p. , 2023
?
4
Most commonly reported side effects in participants receivi..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t003. , 2024
doi:10.1371/journal.pone.0297092.t003. , 2024
?
5
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 fo..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t007. , 2024
doi:10.1371/journal.pone.0297092.t007. , 2024
?
6
Characteristics of prescribed medicinal cannabis users by c..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t001. , 2024
doi:10.1371/journal.pone.0297092.t001. , 2024
?
7
Driving patterns of participants on prescribed THC vs presc..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t006. , 2024
doi:10.1371/journal.pone.0297092.t006. , 2024
?
8
Reported improvement in main condition: comparing prescribe..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t004. , 2024
doi:10.1371/journal.pone.0297092.t004. , 2024
?
9
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 fo..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t007. , 2024
doi:10.1371/journal.pone.0297092.t007. , 2024
?
10
Characteristics of prescribed medicinal cannabis users by c..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t001. , 2024
doi:10.1371/journal.pone.0297092.t001. , 2024
?
11
Reported improvement in main condition: comparing prescribe..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t004. , 2024
doi:10.1371/journal.pone.0297092.t004. , 2024
?
12
Main reasons for use of prescribed medicinal cannabis users..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t002. , 2024
doi:10.1371/journal.pone.0297092.t002. , 2024
?
13
Other medication used versus prescribed cannabinoids:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t005. , 2024
doi:10.1371/journal.pone.0297092.t005. , 2024
?
14
Driving patterns of participants on prescribed THC vs presc..:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t006. , 2024
doi:10.1371/journal.pone.0297092.t006. , 2024
?
15
Other medication used versus prescribed cannabinoids:
Benjamin T. Trevitt ; Sasha Bailey ; Llewellyn Mills...
doi:10.1371/journal.pone.0297092.t005. , 2024
doi:10.1371/journal.pone.0297092.t005. , 2024